Project Title	First Partner	Second Partner	Funding Agency	Starting Date	Closing Date
NeutroCure: Development of “smart” amplifiers of reactive oxygen species specific to aberrant polymorphonuclear neutrophils for treatment of inflammatory and autoimmune diseases, cancer and myeloablation	Friedrich–Alexander University Erlangen–Nürnberg	University of Surrey	EU Research and Innovation programme	2020	2024